Parathyroid hormone-related protein: From hypercalcemia of malignancy to developmental regulatory molecule

American Journal of the Medical Sciences

Volumn 312, Issue 6, 1996, Pages 287-294

  Dunbar, Maureen E ^a   Wysolmerski, John J ^a   Broadus, Arthur E ^a  

^a YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

Developmental regulatory molecule; Humoral hypercalcemia of malignancy (HHM); Organogenesis; Parathyroid hormone (PTH); Parathyroid hormone related protein (PTHrP)

Indexed keywords

COMPLEMENTARY DNA; MESSENGER RNA; PARATHYROID HORMONE; PARATHYROID HORMONE RECEPTOR; PARATHYROID HORMONE RELATED PROTEIN;

AMINO ACID SEQUENCE; DISEASE ASSOCIATION; GENE EXPRESSION; HUMAN; HYPERCALCEMIA; LABORATORY DIAGNOSIS; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; ORGANOGENESIS; OSTEOCLAST; OSTEOLYSIS; PATHOGENESIS; REVIEW; RNA TRANSCRIPTION; SEQUENCE HOMOLOGY; SYNDROME; T CELL LYMPHOMA;

EID: 0029731442     PISSN: 00029629     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0002-9629(15)41844-0     Document Type: Review

References (42)

1. Burtis WJ, Wu T, Bunch C, Wysolmerski JJ, Insogna KL, Weir EC, et al. Identification of a novel 17,000-dalton parathyroid hormone-like adenylate cyclase-stimulating protein from a tumor associated with humoral hypercalcemia of malignancy. J Biol Chem. 1987;262:7151-6.
2. Moseley JM, Kubota M, Diefenbach-Jagger H, Wettenhall EH, Kemp BE, Suva LJ, et al. Parathyroid hormone-related protein purified from a human lung cancer cell line. Proc Natl Acad Sci USA. 1987;84:5048-52.
3. Strewler GJ, Stern PH, Jacobs JW, Evelott J, Klein RF, Leung SC, et al. Parathyroid hormone-like protein from human renal carcinoma cells. Structural and functional homology with parathyroid hormone. J Clin Invest. 1987;80:1803-7.
4. Wysolmerski JJ, Broadus AE. Hypercalcemia of malignancy: the central role of parathyroid hormone-related protein. Annu Rev Med. 1994;45:189-200.
5. Broadus AE, Stewart AF. Parathyroid hormone-related protein structure, processing and physiological actions. In: Bilezikian JP, Marcus R, Levine MA; eds. The Parathyroids. New York: Raven Press; 1994:259-94.
6. Stewart AF, Horst R, Deftos LJ, Cadman EC, Lang R, Broadus AE. Biochemical evaluation of patients with cancer-associated hypercalcemia: evidence for humoral and non-humoral groups. N Engl J Med. 1980;303:1377-83.
7. Broadus AE. Nephrogenous cyclic AMP. Recent Prog Horm Res. 1981;37:667-701.
8. Lafferty FW. Pseudohyperparathyroidism. Medicine (Baltimore). 1966;45:247.
9. Mangin M, Webb AC, Dreyer BE, Posillico JT, Ikeda K, Weir EC, et al. An identification of a cDNA encoding a parathyroid hormone-like peptide from a human tumor associated with humoral hypercalcemia of malignancy. Proc Natl Acad Sci USA. 1988;85:597-601.
10. Suva LJ, Winslow GA, Wettenhall EH, Hammonds RG, Moseley JM, Diefenbach-Jagger H, et al. A parathyroid hormone-related protein implicated in malignant hypercalcemia: cloning and expression. Science. 1987;237:893-6.
11. Mangin M, Ikeda K, Dreyer BE, Broadus AE. Isolation and characterization of the human parathyroid hormone-like peptide gene. Proc Natl Acad Sci USA. 1989;86:2408-42.
12. Orloff JJ, Stewart AF. Parathyroid hormone-like proteins: biochemical responses and receptor interactions. Endocrine Reviews. 1989;10:476-95.
13. Ikeda K, Mangin M, Dreyer BE, Webb AC, Posillico JT, Stewart AF, et al. Identification of transcripts encoding a parathyroid hormone-like peptide in messenger RNAs from a variety of human and animal tumors associated with humoral hypercalcemia of malignancy. J Clin Invest. 1988;81:2010-4.
14. Kemp BE, Moseley JM, Rodda CP, Ebeling PR, Wettenhall REH, Stapelton D, et al. Parathyroid hormone-related protein of malignancy: active synthetic fragments. Science. 1987;238:1568-70.
15. Stewart AF, Mangin M, Wu T, Goumas D, Insogna KL, Burtis WJ, et al. Synthetic human parathyroid hormone-like protein stimulates bone resorption and causes hypercalcemia in rats. J Clin Invest. 1988;81:596-600.
16. Everhart-Caye M, Inzucchi SE, Guinness-Henry J, Mitnick M, Stewart AF. Parathyroid hormone (PTH)-related protein (1-36) is equipotent to PTH (1-34) in humans. J Clin Endocrinol Metab. 1996;81:199-208.
17. Burtis WJ, Brady TG, Orloff JJ, Ersbak JB, Warrell RP Jr, Olson BR, et al. Immunochemical characterization of circulating parathyroid hormone-related protein in patients with humoral hypercalcemia of cancer. N Engl J Med. 1990; 322:1106-12.
18. Kukreja SC, Shevrin DH, Wimbiscus SA, Ebeling PR, Danks JA, Rodda CP, et al. Antibodies to parathyroid hormone-related protein lower serum calcium in athymic mouse models of malignancy-associated hypercalcemia due to human tumors. J Clin Invest. 1988;82:1798.
19. Strewler GJ, Nissenson RA. Hypercalcemia in malignancy. West J Med. 1990;153:635-40.
20. Watanabe T, Yamaguchi K, Takatsuki K, Osama M, Yoshika M. Constitutive expression of parathyroid hormone-related protein gene in human T cell leukemia virus type 1 (HTLV-1) carriers and adult T cell leukemia patients that can be trans-activated by HTLV-1 tax gene. J Exp Med. 1990; 172:759-765.
21. Dittmer J, Gitlin SD, Reid RL, Brady JN. Transactivation of the P2 promoter of parathyroid hormone-related protein by human T-cell lymphotrophic virus type I TaxI: evidence for the involvement of transcription factor Ets1. J Virology. 1993;67:6085-95.
22. Weir EC, Insogna KL, Brownstein DG, Bander NH, Broadus AE. In vitro adenylate cyclase-stimulating activity predicts the occurrence of humoral hypercalcemia of malignancy in nude mice. J Clin Invest. 1988;81:818-21.
23. Holt EH, Vasavada R, Broadus AE, Philbrick WM. Region-specific methylation of the PTH-related peptide gene determines its expression in human renal carcinoma cell lines. J Biol Chem. 1993;268:20639-45.
24. Wysolmerski JJ, Vasavada R, Foley J, Weir EC, Burtis WJ, Kukreja SC, et al. Transactivation of the PTHrP gene in squamous carcinomas predicts the occurrence of hypercalcemia in athymic mice. Cancer Res. 1996;56:1043-9.
25. Foley, J, Wysolmerski, JJ, Broadus, AE, Philbrick, WM. Parathyroid hormone-related protein gene expression in human squamous carcinoma cells is repressed by certain mutant isoforms of p53. Cancer Res. In press.
26. Comings DE. Evidence for ancient tetraploidy and conservation of linkage groups in mammalian chromosomes. Nature. 1972;238:455-7.
27. Pandey AK. Endocrinology of calcium metabolism in amphibians, with emphasis on the evolution of hypercalcemic regulation in Tetrapods. Biological Structures and Morphogenesis. 1992;4:102-26.
28. Jüppner H, Abou-Samra B-B, Freeman M, Kong XF, Schipani E, Richards J, et al. A G protein-linked receptor for parathyroid hormone and parathyroid hormone-related peptide. Science. 1991;254:1024-6.
29. deStolpe A, Karperian M, Lowik CWGM, Juppner H, Segre GV, Abou-Samra AB, et al. Parathyroid hormone-related peptide as an endogenous inducer of parietal endoderm differentiation. J Cell Biol. 1993;120:235-43.
30. Lee K, Deeds JD, Segre GV. Expression of parathyroid hormone-related peptide and its receptor messenger ribonucleic acids during fetal development of rats. Endocrinology. 1995;136:453-63.
31. Bergwitz C, Klein P, Juppner H. Expression of two isoforms of the PTH/PTHrP receptor during Xenopus laevis development. Program of the 10th International Congress of Endocrinology. 1996;OR54-8:726.
32. Karaplis AC, Luz A, Glowacki J, Bronson RJ, Tybolewicz VLJ, Kronenberg HM, et al. Lethal skeletal dysplasia from targeted disruption of the parathyroid hormone-related peptide gene. Genes and Dev. 1994;8:277-89.
33. Weir EC, Philbrick WM, Amling M, Neff LA, Baron RE, Broadus AE. Targeted overexpression of parathyroid hormone-related peptide in chondrocytes causes chondrodysplasia and delayed endochondral bone formation. Proc Nat Acad Sci USA. In press.
34. Lee K, Deeds JD, Bond AT, Juppner H, Abou-Samra AB, Segre GV. In situ localization of PTH/PTHrP receptor mRNA in the bone of fetal and young rats. Bone. 1993;14:341-5.
35. Iwamoto M, Akitoshi J, Murakami H, Shimazu A, Nakashima K, Iwamoto M, et al. Changes in parathyroid hormone receptors during chondrocyte cytodifferentiation. J Biol Chem. 1994;269:17245-51.
36. Henderson JE, Amizuka N, Warshawsky H, Biasotto D, Lanske BM, Goltzman D, et al. Nucleolar localization of parathyroid hormone-related peptide enhances survival of chondrocytes under conditions that promote apoptotic cell death. Mol Cell Biol. 1995;15:4064-75.
37. Schipani E, Kruse K, Juppner H. A constitutively active mutant PTH-PTHrP receptor in Jansen-type metaphyseal chondrodysplasia. Science. 1995;268:98-100.
38. Wysolmerski JJ, Broadus AE, Zhou J, Fuchs E, Milstone LM, Philbrick WM. Overexpression of parathyroid hormone-related protein in the skin of transgenic mice interfers with hair follicle development. Proc Natl Acad Sci USA. 1994;91:1133-7.
39. Rakopoulos M, Vargas SJ, Gillespie MT, Ho PWM, Diefenbach-Jagger H, Leaver DL, et al. Production of parathyroid hormone-related protein by the rat mammary gland in pregnancy and lactation. Am J Physiol. 1992;263:E1077-85.
40. Seitz PK, Cooper KM, Ives KL, Ishizuka J, Townsend CM, Rajsraman S, et al. Parathyroid hormone-related peptide production and action in a myoepithelial cell line derived from normal human breast. Endocrinology. 1993;133:1116-24.
41. Wysolmerski JJ, McCaughern-Carucci JF, Daifotis AG, Broadus AE, Philbrick WM. Overexpression of parathyroid hormone-related protein or parathyroid hormone in transgenic mice impairs branching morphogenesis during mammary gland development. Development. 1995; 121:3539-47.
42. Stewart AF, Vignery A, Silvergate A, et al. Quantitative bone histomorphometry in humoral hypercalcemia of malignancy: uncoupling of bone cell activity. J Clin Endocrinol Metab. 1982;55:219-27.